Edit
Rivermark Medical, Inc.
https://www.rivermarkmedical.com/Last activity: 15.05.2026
Probably Closed
Minimally Invasive Device Therapy for BPH
Location: United States
Employees: 1-10
Total raised: $52.1M
Investors 1
| Date | Name | Website |
| 15.05.2026 | Andera Par... | anderapart... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 13.05.2026 | Series D | $20M | Andera Par... |
| 15.10.2024 | Series C | $30M | - |
| 27.07.2023 | - | $2.1M | - |
Mentions in press and media 11
| Date | Title | Description |
| 13.05.2026 | Andera Partners Leads $20 Million Series D Financing in Rivermark Medical. | Andera Partners, a leading European venture capital and private equity firm, today announced it led a $20 million Series D financing in Rivermark Medical, Inc., a urology-focused medical device company committed to redefining benign prostat... |
| 06.08.2025 | Wisconsin startup funding dips in 2024 but deal size hits decade high | Wisconsin’s early stage companies raised a combined $374.1 million in 2024 across 92 deals, according to the Wisconsin Technology Council’s newly released Wisconsin Portfolio. While the total marked the state’s lowest since 2018, the median... |
| 12.11.2024 | Wisconsin VC Funding for October 2024 | According to PitchBook, Wisconsin startups raised at least $49.74 million in disclosed funding during October. Rivermark Medical raised $30.04 million of Series C venture funding in a deal led by American Century Investments. The funds will... |
| 17.10.2024 | Rivermark Medical Secures $30 Million to Revolutionize BPH Treatment | Rivermark Medical is on the brink of a breakthrough. The Milwaukee-based company has successfully raised $30 million in a Series C funding round. This financial boost is set to propel the development of its flagship product, the FloStent Sy... |
| 15.10.2024 | Rivermark Medical: $30 Million (Series C) Closed To Advance Development Of Flostent | Rivermark Medical, a leader in minimally invasive solutions for Benign Prostatic Hyperplasia (BPH), announced the closing of a $30 million Series C financing round. The funding round was led by American Century Investments (ACI), including ... |
| 10.10.2024 | Rivermark Medical Raises $30M in Series C Funding | Rivermark Medical, a Milwaukee, WI-based company which specializes in minimally invasive solutions for Benign Prostatic Hyperplasia (BPH), raised $30M in Series C funding. The round was led by American Century Investments (ACI) including ne... |
| 28.08.2023 | Wisconsin VC Funding for July 2023 | According to Pitchbook, Wisconsin startups raised at least $10.65 million in July. Milwaukee-based Rivermark Medical has developed a therapeutic device that provides a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH). Le... |
| - | Rivermark Medical | “Restore Flow, Preserve Options.FloStent is a first-line device treatment for BPH, delivered in the outpatient setting during a routine cystoscopy using a standard flexible cystoscope. The FloStent is designed to immediately restore normal ... |
| - | Manage your consent preferences Rivermark Medical raises $30M to advance commercialization of first product | - |
| - | Rivermark Medical raises $30M to advance commercialization of first product | - |
Show more